GSK plc June 2026 Form 6-K: Share Reward Plan Transactions for Senior Executives
This GSK plc Form 6-K filing reports multiple share acquisitions by senior executives and their closely associated persons under the company's Share Reward Plan on June 9, 2026. Eight senior executives, including CFO Julie Brown, President of Europe Lynn Baxter, SVP and Group General Counsel James Ford, President of Corporate Development David Redfern, President of Global Supply Chain Regis Simard, President of Global Affairs Philip Thomson, CEO of ViiV Healthcare Deborah Waterhouse, and SVP & Company Secretary Victoria Whyte, each acquired 14 ordinary shares (except Whyte who acquired 12 shares) at a price of Β£18.8393 per share. Additionally, Neil Falkingham, a person closely associated with Lynn Baxter, also acquired 12 shares. All transactions were executed on the London Stock Exchange and represent a combination of partnership shares and matching shares under the company's compensation plan.